Drug:
Reaction: BLOOD GLUCOSE INCREASED
20250101 - 20251231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 25081509 |
US |
65 | 1 |
Blood glucose increased, Muscle atrophy, Accidental underdose, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, EVOLOCUMAB, EMPAGLIFLOZIN, |
||||
| 302 | 25081626 |
US |
62 | 1 |
Accidental underdose, Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, |
||||
| 303 | 25081674 |
US |
56 | 2 |
Blood glucose increased, Off label use, Blood glucose decreased, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 304 | 25081676 |
US |
59 | 1 |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 305 | 25081719 |
US |
||
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 306 | 25080302 |
US |
58 | 2 |
Weight increased, Incorrect dose administered, Blood glucose increased, Diabetic neuropathy, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 307 | 25080351 |
US |
61 | 2 |
Blood glucose increased, Injection site swelling, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN DEGLUDEC, |
||||
| 308 | 25080975 |
US |
43 | 2 |
Wrong technique in product usage process, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 309 | 25081107 |
US |
51 | 1 |
Blood glucose increased, Drug ineffective, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
||||
| 310 | 25077016 |
US |
89 | 2 |
Visual impairment, Glycosylated haemoglobin increased, Blood glucose increased, Expired product administered, |
||||
DULAGLUTIDE, DULAGLUTIDE, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 311 | 25077579 |
US |
66 | 1 |
Product dose omission issue, Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 312 | 25077822 |
US |
65 | |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 313 | 25078385 |
JP |
40 | 2 |
Renal impairment, Blood glucose increased, |
||||
PEMBROLIZUMAB, PACLITAXEL, CARBOPLATIN, |
||||
| 314 | 25079066 |
US |
66 | 2 |
Increased appetite, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 315 | 25079698 |
US |
39 | 1 |
Blood glucose increased, Therapy change, Inability to afford medication, Insurance issue, |
||||
ERTUGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, |
||||
| 316 | 25079920 |
CA |
89 | 2 |
Hypoglycaemia, Asthenia, Unresponsive to stimuli, Body temperature decreased, Blood glucose increased, Drug ineffective, Amnesia, Self-medication, Overdose, |
||||
LINAGLIPTIN, INSULIN GLARGINE, MIRTAZAPINE, PRAMIPEXOLE DIHYDROCHLORIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, GABAPENTIN, PENTOXIFYLLINE, ROSUVASTATIN, STANDARDIZED SENNA CONCENTRATE, SOLIFENACIN, ERGOCALCIFEROL, |
||||
| 317 | 25079930 |
US |
1 | |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO-AABC, |
||||
| 318 | 25080073 |
US |
58 | 1 |
Cerebrovascular accident, Shoulder fracture, Insomnia, Blood glucose increased, Wrong technique in product usage process, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 319 | 25080106 |
PL |
78 | |
Blood glucose increased, |
||||
DAPAGLIFLOZIN, |
||||
| 320 | 25071693 |
US |
||
Device infusion issue, Blood glucose increased, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 321 | 25072242 |
US |
82 | 1 |
Blood glucose increased, Injury associated with device, Product administered at inappropriate site, Injection site mass, Incorrect dose administered, |
||||
DULAGLUTIDE, |
||||
| 322 | 25072596 |
US |
77 | 2 |
Drug ineffective, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 323 | 25072903 |
US |
69 | 2 |
Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 324 | 25072939 |
US |
98 | 2 |
Blood glucose increased, Device defective, |
||||
INSULIN GLARGINE, |
||||
| 325 | 25073029 |
US |
54 | 2 |
Memory impairment, Hunger, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 326 | 25073083 |
US |
73 | 2 |
Blood glucose increased, Muscle spasms, Onychoclasis, Alopecia, |
||||
TEPROTUMUMAB, |
||||
| 327 | 25073148 |
US |
59 | 1 |
Vision blurred, Headache, Feeling abnormal, Memory impairment, Dehydration, Abdominal pain upper, Blood glucose increased, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, BUPROPION HYDROCHLORIDE, |
||||
| 328 | 25073162 |
US |
63 | |
Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 329 | 25073188 |
AU |
62 | 1 |
Central nervous system vasculitis, Sensory disturbance, Agnosia, Blood glucose increased, Blood immunoglobulin G decreased, Blood immunoglobulin M decreased, Clonus, Hypermetabolism, Hypometabolism, Inflammation, Night sweats, Platelet count increased, Blood pressure increased, Confusional state, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISONE, |
||||
| 330 | 25073470 |
IN |
42 | 2 |
Shock, Blood potassium abnormal, Blood calcium abnormal, Blood glucose increased, Intentional overdose, |
||||
AMLODIPINE, GLIMEPIRIDE, |
||||
| 331 | 25073578 |
US |
58 | 1 |
Blood glucose increased, Product dispensing error, |
||||
INSULIN GLARGINE, |
||||
| 332 | 25073603 |
IN |
||
Shock, Blood potassium abnormal, Blood calcium abnormal, Blood glucose increased, Toxicity to various agents, Intentional overdose, |
||||
AMLODIPINE, GLIMEPIRIDE, |
||||
| 333 | 25073679 |
US |
67 | 1 |
Blood glucose increased, Accidental overdose, |
||||
DULAGLUTIDE, |
||||
| 334 | 25074027 |
US |
85 | 1 |
Blood glucose increased, Intentional product misuse, |
||||
INSULIN GLULISINE, INSULIN GLARGINE, |
||||
| 335 | 25074109 |
US |
62 | 1 |
Blood glucose increased, Anxiety, Nausea, Nervousness, Blood glucose decreased, |
||||
INSULIN LISPRO, |
||||
| 336 | 25074687 |
IN |
67 | 1 |
Off label use, Thrombocytopenia, Eosinophilia, Haemoglobin decreased, Haematocrit decreased, Blood creatinine decreased, Bilirubin conjugated increased, Blood glucose increased, Spinal osteoarthritis, Oesophageal disorder, Gastric ulcer, Red blood cell count decreased, White blood cell count decreased, Monocyte count increased, Normochromic normocytic anaemia, Monocytosis, Melaena, Pulmonary mass, Hepatic lesion, Blood bilirubin increased, Glycosylated haemoglobin increased, Illness, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, BEVACIZUMAB, |
||||
| 337 | 25074744 |
US |
31 | 1 |
Localised infection, Localised infection, Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 338 | 25074749 |
US |
40 | 1 |
Pneumonia, Influenza, Blood glucose increased, Incorrect product administration duration, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 339 | 25074772 |
US |
63 | 2 |
Colitis ischaemic, Drug ineffective, Blood glucose increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 340 | 25075173 |
JP |
74 | 2 |
Urinary tract infection, Lung adenocarcinoma, Blood glucose increased, Hypertension, Chronic kidney disease, |
||||
SITAGLIPTIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 341 | 25075183 |
72 | 2 | |
Blood glucose increased, |
||||
TEZEPELUMAB-EKKO, |
||||
| 342 | 25075296 |
US |
69 | 1 |
Blood glucose increased, Memory impairment, Incorrect dose administered, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 343 | 25075883 |
JP |
74 | |
Nephrotic syndrome, Pneumonia, Decreased appetite, Cardiac failure, Oedema, Blood glucose increased, Treatment noncompliance, |
||||
DAPAGLIFLOZIN, DAPAGLIFLOZIN, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, NIFEDIPINE, NIFEDIPINE, FUROSEMIDE, FUROSEMIDE, TOLVAPTAN, TOLVAPTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, LANSOPRAZOLE, LANSOPRAZOLE, ZINC ACETATE, SODIUM ZIRCONIUM CYCLOSILICATE, |
||||
| 344 | 25075949 |
US |
47 | 1 |
Blood glucose increased, Haemoglobin increased, |
||||
TREPROSTINIL, AMLODIPINE BESYLATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, FOLIC ACID, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ERGOCALCIFEROL, KETAMINE HYDROCHLORIDE, TADALAFIL, PREDNISONE, CLONIDINE, KETOPROFEN, SPIRONOLACTONE, BUMETANIDE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MAGNESIUM, AMITRIPTYLINE HYDROCHLORIDE, GABAPENTIN, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, SIMVASTATIN, |
||||
| 345 | 25076351 |
CN |
59 | 1 |
Renal necrosis, Transitional cell carcinoma, Blood glucose increased, Glomerular filtration rate decreased, Blood creatinine increased, Drug ineffective, |
||||
BUDESONIDE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, |
||||
| 346 | 25076459 |
US |
58 | 2 |
Product dose omission issue, Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN DETEMIR, |
||||
| 347 | 25076490 |
US |
66 | |
Blood glucose increased, Product dose omission issue, |
||||
INSULIN LISPRO, |
||||
| 348 | 25076714 |
US |
||
Confusional state, Blood glucose abnormal, Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, SITAGLIPTIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TORSEMIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ENZALUTAMIDE, ALLOPURINOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CILOSTAZOL, GLIMEPIRIDE, |
||||
| 349 | 25076748 |
US |
||
Blood glucose increased, Hunger, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 350 | 25076806 |
IN |
65 | 2 |
Breast cancer, Recurrent cancer, Aspiration, Swelling, Blood cholesterol increased, Blood glucose increased, Cholelithiasis, Osteopenia, Seroma, |
||||
EXEMESTANE, |
||||
| 351 | 25066021 |
CN |
57 | 2 |
Hypertension, Blood glucose increased, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLYBURIDE, |
||||
| 352 | 25066350 |
KR |
||
Seizure, Blood glucose increased, Chest pain, Aphasia, Muscle spasms, Skin disorder, Muscular weakness, Blood glucose fluctuation, Hypoglycaemia, Product administration interrupted, |
||||
OSIMERTINIB, OSIMERTINIB, |
||||
| 353 | 25066472 |
US |
53 | 2 |
Blood glucose increased, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 354 | 25066797 |
CA |
65 | 1 |
Blood glucose increased, Blood pressure fluctuation, Blood pressure increased, Blood pressure systolic increased, Chest discomfort, Diabetes mellitus, Dyspnoea, Heart rate abnormal, Hypertension, Muscular weakness, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, BISOPROLOL FUMARATE, CANAGLIFLOZIN, EZETIMIBE, FUROSEMIDE, LIRAGLUTIDE, SPIRONOLACTONE, TERAZOSIN, TERAZOSIN HYDROCHLORIDE, INSULIN DEGLUDEC, |
||||
| 355 | 25066841 |
US |
82 | 2 |
Blood glucose increased, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN DETEMIR, |
||||
| 356 | 25066966 |
US |
||
Product label confusion, Medication error, Blood glucose increased, |
||||
DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 357 | 25067221 |
US |
||
Blood glucose increased, Haemoglobin decreased, Hot flush, Fatigue, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
| 358 | 25067289 |
US |
||
Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, HYDROCHLOROTHIAZIDE, FELODIPINE, FELODIPINE EXTENDED-RELEASE TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, GUAIFENESIN, ERGOCALCIFEROL, ROSUVASTATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ALBUTEROL SULFATE, ALBUTEROL, INSULIN GLARGINE, LISINOPRIL, |
||||
| 359 | 25067408 |
US |
||
Blood glucose increased, |
||||
RELUGOLIX, RELUGOLIX, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GABAPENTIN, METHOCARBAMOL, METHOCARBAMOL TABLETS, TADALAFIL, |
||||
| 360 | 25067841 |
US |
||
Blood glucose increased, Hot flush, Asthenia, |
||||
RELUGOLIX, RELUGOLIX, ALPRAZOLAM, BUPROPION HYDROCHLORIDE, ERGOCALCIFEROL, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, CHOLESTYRAMINE, ASPIRIN, |
||||
| 361 | 25067851 |
US |
||
Blood cholesterol abnormal, Headache, Blood glucose increased, Weight increased, Product dose omission issue, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 362 | 25068252 |
US |
56 | 2 |
Overdose, Blood pressure increased, Burning sensation, Ocular hyperaemia, Fatigue, Drug ineffective, Blood glucose increased, Glycosylated haemoglobin increased, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 363 | 25068432 |
US |
2 | |
Blood glucose increased, Product dose omission issue, Device mechanical issue, |
||||
INSULIN GLARGINE, |
||||
| 364 | 25068581 |
US |
69 | 2 |
Glycosylated haemoglobin increased, Blood glucose increased, Product quality issue, Poor quality product administered, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 365 | 25068674 |
US |
77 | 1 |
Blood glucose increased, Device mechanical issue, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, |
||||
| 366 | 25068696 |
US |
67 | 1 |
Blood glucose increased, |
||||
INSULIN GLARGINE, |
||||
| 367 | 25068724 |
US |
71 | 2 |
Blood glucose increased, Device operational issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 368 | 25068737 |
US |
28 | 2 |
Blood glucose increased, Blindness, Malaise, Haematological infection, Skin ulcer, Surgery, Device mechanical issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 369 | 25069451 |
US |
48 | 2 |
Blood glucose increased, |
||||
INSULIN GLARGINE, INSULIN HUMAN, SITAGLIPTIN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 370 | 25070020 |
US |
16 | 2 |
Blood glucose increased, Sleep disorder, Illness, Product dose omission issue, |
||||
DORNASE ALFA, LANSOPRAZOLE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 371 | 25070125 |
ES |
63 | 2 |
Diverticulitis, Diabetes mellitus inadequate control, Loss of consciousness, Hypoglycaemia, Decreased appetite, Diarrhoea, Memory impairment, Condition aggravated, Nocturia, Nervousness, Vulvovaginal pruritus, Blood glucose increased, Blood glucose fluctuation, Intentional product misuse, |
||||
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, EMPAGLIFLOZIN, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 372 | 25070277 |
US |
75 | 2 |
Blood glucose increased, Panic attack, Product dose omission issue, Injection site bruising, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 373 | 25070474 |
US |
37 | 2 |
Blood glucose increased, Device defective, Intentional product misuse, Maternal exposure during pregnancy, |
||||
INSULIN GLARGINE, |
||||
| 374 | 25070823 |
US |
88 | 2 |
Blood glucose increased, Device issue, Product storage error, |
||||
INSULIN GLARGINE, |
||||
| 375 | 25070866 |
US |
77 | 2 |
Injection site indentation, Blood glucose increased, Drug dose omission by device, Device mechanical issue, Device use issue, |
||||
INSULIN LISPRO, INSULIN LISPRO, |
||||
| 376 | 25070882 |
US |
82 | 1 |
Blood glucose increased, Device issue, Intentional product misuse, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 377 | 25071002 |
US |
1 | |
Hypersensitivity, Bell^s palsy, Blood glucose increased, |
||||
PANCRELIPASE, |
||||
| 378 | 25071092 |
US |
41 | 2 |
Drug ineffective, Blood glucose increased, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 379 | 25071238 |
US |
82 | 2 |
Oxygen saturation decreased, Dyspnoea, Pneumonia, Myocardial necrosis marker increased, Hypervolaemia, Fibrosis, Feeling abnormal, Blood glucose increased, Headache, Diarrhoea, Productive cough, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PREDNISONE, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, PANTOPRAZOLE SODIUM, SERTRALINE HYDROCHLORIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, OXYGEN, 0XYGEN, ALPRAZOLAM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, BUDESONIDE, |
||||
| 380 | 25061436 |
US |
78 | 2 |
Pneumonia viral, Pneumonia, Pelvic fracture, Spinal cord disorder, Intervertebral disc protrusion, Arthralgia, Brain fog, Blood glucose increased, Dizziness, Speech disorder, Fungal foot infection, Back pain, Influenza, |
||||
EVOLOCUMAB, |
||||
| 381 | 25061443 |
US |
76 | 2 |
Blindness, Vaginal infection, Blood glucose increased, |
||||
EMPAGLIFLOZIN, DULAGLUTIDE, |
||||
| 382 | 25061463 |
CO |
2 | |
Cataract, Pain in extremity, Pain in extremity, Glycosylated haemoglobin increased, Blood glucose increased, |
||||
SEMAGLUTIDE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 383 | 25061643 |
US |
1 | |
Surgery, Blood glucose increased, Dizziness, Pyrexia, Drug ineffective, Product storage error, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 384 | 25061961 |
US |
63 | 1 |
Vision blurred, Head discomfort, Lethargy, Blood glucose increased, Drug ineffective, Blood glucose decreased, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 385 | 25062305 |
US |
49 | 1 |
Blood glucose increased, Sensitive skin, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 386 | 25062360 |
US |
2 | |
Sepsis, Skin ulcer, Wound infection, Cellulitis, Second degree chemical burn of skin, Wound necrosis, Muscle necrosis, Application site pain, Skin burning sensation, Body mass index increased, Blood pressure systolic increased, Blood pressure diastolic increased, Blood creatinine decreased, Red cell distribution width increased, Blood glucose increased, Carbon dioxide increased, Haematocrit decreased, Immature granulocyte percentage increased, Activated partial thromboplastin time prolonged, Heart rate decreased, Hypernatraemia, Protein total decreased, Leukopenia, Hyperchloraemia, Dermatitis, Mean cell haemoglobin concentration decreased, Neutrophil count decreased, Skin lesion, Hypoaesthesia, Muscle hypertrophy, Peripheral swelling, Limb injury, Blister, Pain in extremity, Furuncle, Mobility decreased, Stasis dermatitis, Peripheral venous disease, Lymphoedema, Venous hypertension, |
||||
LIDOCAINE HCL AND MENTHOL, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, APIXABAN, APIXABAN, APIXABAN, APIXABAN, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, MONTELUKAST SODIUM, DOXEPIN, DOXEPIN HYDROCHLORIDE, LINACLOTIDE, LINACLOTIDE, AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM, LIDOCAINE PATCH 5%, VITAMIN C, FERROUS SULFATE, SILVER SULFADIAZINE, TAPENTADOL HYDROCHLORIDE, ATORVASTATIN CALCIUM, ERGOCALCIFEROL, |
||||
| 387 | 25062904 |
US |
79 | 1 |
Blood glucose increased, |
||||
PANTOPRAZOLE, RELUGOLIX, ATENOLOL, GABAPENTIN, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, ESCITALOPRAM, ATORVASTATIN CALCIUM, MEGESTROL ACETATE, REPAGLINIDE, RIVAROXABAN, DENOSUMAB, |
||||
| 388 | 25063186 |
US |
||
Cardiac failure congestive, Renal disorder, Hypoaesthesia, Blood glucose increased, Swelling, Musculoskeletal stiffness, Hot flush, Insomnia, Chills, Dyspnoea, |
||||
SELINEXOR, ALBUTEROL SULFATE, CARVEDILOL, METOLAZONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, APIXABAN, INSULIN LISPRO, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, TRAMADOL HYDROCHLORIDE, INSULIN DEGLUDEC, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 389 | 25063576 |
CN |
52 | 1 |
Intestinal obstruction, Cognitive disorder, Abdominal pain, Constipation, Blood glucose increased, Lipids increased, Proteinuria, Hypersensitivity, |
||||
LORLATINIB, LORLATINIB, |
||||
| 390 | 25064188 |
US |
42 | 1 |
Blood glucose increased, |
||||
BUDESONIDE, |
||||
| 391 | 25064290 |
US |
2 | |
Blood glucose increased, |
||||
INSULIN LISPRO, |
||||
| 392 | 25064348 |
US |
57 | 2 |
Blood glucose increased, Nausea, |
||||
TIRZEPATIDE, |
||||
| 393 | 25064546 |
US |
43 | |
Blood glucose increased, Extra dose administered, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 394 | 25065004 |
US |
5 | 1 |
Blood glucose increased, |
||||
LORATADINE, LORATADINE TABLET, |
||||
| 395 | 25065038 |
US |
64 | 2 |
Blood glucose increased, Product storage error, |
||||
INSULIN HUMAN, |
||||
| 396 | 25065109 |
US |
69 | 1 |
Blood glucose increased, Product storage error, |
||||
INSULIN LISPRO, |
||||
| 397 | 25065244 |
US |
2 | |
Hepatic enzyme increased, Blood glucose increased, |
||||
PEMBROLIZUMAB, PREDNISONE, |
||||
| 398 | 25056258 |
US |
68 | 1 |
Lung disorder, Blood glucose increased, Wrong technique in product usage process, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 399 | 25056317 |
US |
51 | 2 |
Cardiac disorder, Drug hypersensitivity, Rheumatoid arthritis, Memory impairment, Blood glucose increased, Fungal infection, |
||||
EMPAGLIFLOZIN, DULAGLUTIDE, DULAGLUTIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 400 | 25056399 |
PL |
29 | 2 |
Ketonuria, Malaise, Large for dates baby, Oligohydramnios, Blood glucose increased, Maternal exposure during pregnancy, |
||||
INSULIN DETEMIR, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28